Press releases
Nolsterby Invest AB, controlled by Board members Erik Hedlund and Anders Hedlund, has during the period April 2-April 5 ...
The Board has decided to appoint Anders Hedlund as interim CEO of the company. He replaces thereby Lars Gusch who ...
The shareholders of Pharmacolog i Uppsala AB (publ), reg. no. 556723-6418 (the "Company"), are hereby invited to an extraordinary ...
The Board of Directors has decided to proceed with the previously communicated business change. Against this background, Pharmacolog will convene ...
The company has decided by mutual agreement that Lars Gusch will step down from his current position as CEO on ...
NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, ...
NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, ...
NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, ...
Press release: Uppsala, February 16, 2024 Pharmacolog i Uppsala AB (publ) year-end bulletin for the period January - December 2023 ...
Within the framework of the Board's established strategy, a significant milestone was recently communicated with the sale of Druglog ...